DE60331479D1 - Pyrimidin-derivate zur behandlung von anormalem zellwachstum - Google Patents
Pyrimidin-derivate zur behandlung von anormalem zellwachstumInfo
- Publication number
- DE60331479D1 DE60331479D1 DE60331479T DE60331479T DE60331479D1 DE 60331479 D1 DE60331479 D1 DE 60331479D1 DE 60331479 T DE60331479 T DE 60331479T DE 60331479 T DE60331479 T DE 60331479T DE 60331479 D1 DE60331479 D1 DE 60331479D1
- Authority
- DE
- Germany
- Prior art keywords
- cell growth
- abnormal cell
- pyrimidine derivatives
- treating abnormal
- treating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 230000002159 abnormal effect Effects 0.000 title 1
- 230000010261 cell growth Effects 0.000 title 1
- 229940083082 pyrimidine derivative acting on arteriolar smooth muscle Drugs 0.000 title 1
- 150000003230 pyrimidines Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US43567002P | 2002-12-20 | 2002-12-20 | |
US50074203P | 2003-09-05 | 2003-09-05 | |
PCT/IB2003/005883 WO2004056807A1 (en) | 2002-12-20 | 2003-12-08 | Pyrimidine derivatives for the treatment of abnormal cell growth |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60331479D1 true DE60331479D1 (de) | 2010-04-08 |
Family
ID=32685406
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60331479T Expired - Lifetime DE60331479D1 (de) | 2002-12-20 | 2003-12-08 | Pyrimidin-derivate zur behandlung von anormalem zellwachstum |
Country Status (31)
Country | Link |
---|---|
US (4) | US7109335B2 (de) |
EP (1) | EP1625121B1 (de) |
AP (1) | AP2385A (de) |
AR (1) | AR043682A1 (de) |
AT (1) | ATE458731T1 (de) |
AU (2) | AU2003285614B2 (de) |
CA (1) | CA2529611C (de) |
CR (2) | CR8266A (de) |
CY (1) | CY1110069T1 (de) |
DE (1) | DE60331479D1 (de) |
DK (1) | DK1625121T3 (de) |
DO (1) | DOP2003000793A (de) |
EA (1) | EA013248B1 (de) |
EC (1) | ECSP066406A (de) |
ES (1) | ES2338545T3 (de) |
GE (1) | GEP20084357B (de) |
IL (1) | IL172047A (de) |
MX (1) | MXPA06002608A (de) |
MY (1) | MY142109A (de) |
NL (1) | NL1025067C2 (de) |
NZ (1) | NZ543719A (de) |
OA (1) | OA13309A (de) |
PA (1) | PA8593001A1 (de) |
PE (1) | PE20041016A1 (de) |
PL (1) | PL379330A1 (de) |
PT (1) | PT1625121E (de) |
RS (1) | RS20060097A (de) |
SI (1) | SI1625121T1 (de) |
TN (1) | TNSN06074A1 (de) |
TW (1) | TWI283673B (de) |
WO (1) | WO2004056807A1 (de) |
Families Citing this family (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004056807A1 (en) | 2002-12-20 | 2004-07-08 | Pfizer Products Inc. | Pyrimidine derivatives for the treatment of abnormal cell growth |
US7109337B2 (en) | 2002-12-20 | 2006-09-19 | Pfizer Inc | Pyrimidine derivatives for the treatment of abnormal cell growth |
DE10349423A1 (de) * | 2003-10-16 | 2005-06-16 | Schering Ag | Sulfoximinsubstituierte Parimidine als CDK- und/oder VEGF-Inhibitoren, deren Herstellung und Verwendung als Arzneimittel |
WO2005111016A1 (en) * | 2004-05-14 | 2005-11-24 | Pfizer Products Inc. | Pyrimidine derivatives for the treatment of abnormal cell growth |
US20060205945A1 (en) * | 2004-05-14 | 2006-09-14 | Pfizer Inc | Pyrimidine derivatives for the treatment of abnormal cell growth |
BRPI0510980A (pt) | 2004-05-14 | 2007-11-27 | Pfizer Prod Inc | derivados de pirimidina para o tratamento do crescimento anormal de células |
BRPI0511132A (pt) * | 2004-05-14 | 2007-11-27 | Pfizer Prod Inc | derivados de pirimidina e composição farmacêutica compreendendo os mesmos |
WO2005111023A1 (en) * | 2004-05-14 | 2005-11-24 | Pfizer Products Inc. | Pyrimidine derivatives for the treatment of abnormal cell growth |
CA2566531A1 (en) * | 2004-05-18 | 2005-12-15 | Rigel Pharmaceuticals, Inc. | Cycloalkyl substituted pyrimidinediamine compounds and their uses |
CA2571482A1 (en) * | 2004-06-21 | 2005-12-29 | Pharmacia & Upjohn Company Llc | Pyk2 inhibitors for stimulation of osteoblast function |
EP1741709A1 (de) * | 2005-06-28 | 2007-01-10 | Sanofi-Aventis Deutschland GmbH | Heteroaryl substituierte Amide mit gesättigtem Linker, und deren Verwendung als Pharmaka |
BRPI0618011A2 (pt) * | 2005-10-28 | 2011-08-16 | Astrazeneca Ab | composto ou um sal farmaceuticamente aceitável do mesmo, processo para a preparação do mesmo, composição farmacêutica, uso de um composto ou um sal farmaceuticamente aceitável do mesmo, e, métodos para produzir um efeito anti-proliferativo e um efeito pró-apoptósico em um animal de sangue quente, para tratar doença e para produzir um efeito inibidor de jak em um animal de sangue quente |
CA2632149C (en) * | 2005-12-01 | 2011-11-15 | Pfizer Products Inc. | Pyrimidine derivatives for the treatment of abnormal cell growth |
WO2008049123A2 (en) | 2006-10-19 | 2008-04-24 | Rigel Pharmaceuticals, Inc. | 2,4-pyrimidinediamine derivatives as inhibitors of jak kinases for the treatment of autoimmune diseases |
DE102007010801A1 (de) * | 2007-03-02 | 2008-09-04 | Bayer Cropscience Ag | Diaminopyrimidine als Fungizide |
CN101801401A (zh) * | 2007-03-16 | 2010-08-11 | 佛罗里达大学研究基金会 | 激酶蛋白质结合抑制剂 |
MX2009011090A (es) | 2007-04-18 | 2009-11-02 | Pfizer Prod Inc | Derivados de sulfonil amida para el tratamiento del crecimiento celular anormal. |
KR101294731B1 (ko) * | 2007-06-04 | 2013-08-16 | 삼성디스플레이 주식회사 | 어레이 기판, 이를 갖는 표시패널 및 이의 제조방법 |
KR20100049068A (ko) | 2007-07-17 | 2010-05-11 | 리겔 파마슈티칼스, 인크. | Pkc 억제제로서의 시클릭 아민 치환된 피리미딘디아민 |
CL2009000600A1 (es) * | 2008-03-20 | 2010-05-07 | Bayer Cropscience Ag | Uso de compuestos de diaminopirimidina como agentes fitosanitarios; compuestos de diaminopirimidina; su procedimiento de preparacion; agente que los contiene; procedimiento para la preparacion de dicho agente; y procedimiento para combatir plagas de animales y/u hongos dañinos patogenos de plantas. |
EP2161259A1 (de) | 2008-09-03 | 2010-03-10 | Bayer CropScience AG | 4-Halogenalkylsubstituierte Diaminopyrimidine als Fungizide |
US8410126B2 (en) * | 2009-05-29 | 2013-04-02 | Boehringer Ingelheim International Gmbh | Pyrimidine inhibitors of PKTK2 |
TW201100441A (en) | 2009-06-01 | 2011-01-01 | Osi Pharm Inc | Amino pyrimidine anticancer compounds |
US8933227B2 (en) | 2009-08-14 | 2015-01-13 | Boehringer Ingelheim International Gmbh | Selective synthesis of functionalized pyrimidines |
JP5539518B2 (ja) | 2009-08-14 | 2014-07-02 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 2−アミノ−5−トリフルオロメチルピリミジン誘導体の位置選択的調製 |
EP2395001A1 (de) | 2010-05-21 | 2011-12-14 | Chemilia AB | Neue Pyrimidinderivate |
AU2011254550B2 (en) | 2010-05-21 | 2013-11-07 | Noviga Research Ab | Novel pyrimidine derivatives |
US8628554B2 (en) | 2010-06-13 | 2014-01-14 | Virender K. Sharma | Intragastric device for treating obesity |
US10010439B2 (en) | 2010-06-13 | 2018-07-03 | Synerz Medical, Inc. | Intragastric device for treating obesity |
US10420665B2 (en) | 2010-06-13 | 2019-09-24 | W. L. Gore & Associates, Inc. | Intragastric device for treating obesity |
US9526648B2 (en) | 2010-06-13 | 2016-12-27 | Synerz Medical, Inc. | Intragastric device for treating obesity |
DE102010034699A1 (de) | 2010-08-18 | 2012-02-23 | Merck Patent Gmbh | Pyrimidinderivate |
US20120244141A1 (en) | 2010-09-28 | 2012-09-27 | Boehringer Ingelheim International Gmbh | Stratification of cancer patients for susceptibility to therapy with PTK2 inhibitors |
PT2646448T (pt) | 2010-11-29 | 2017-10-04 | Osi Pharmaceuticals Llc | Inibidores macrocíclicos de cinases |
EP2675794B1 (de) | 2011-02-17 | 2019-02-13 | Cancer Therapeutics Crc Pty Limited | Selektive fak-inhibitoren |
CA2827171C (en) | 2011-02-17 | 2019-04-09 | Cancer Therapeutics Crc Pty Limited | Fak inhibitors |
EP2502924A1 (de) | 2011-03-24 | 2012-09-26 | Chemilia AB | Neue Pyrimidinderivate |
CA2830129C (en) | 2011-03-24 | 2016-07-19 | Chemilia Ab | Novel pyrimidine derivatives |
DE102011111400A1 (de) | 2011-08-23 | 2013-02-28 | Merck Patent Gmbh | Bicyclische heteroaromatische Verbindungen |
EP3121173A1 (de) * | 2011-11-29 | 2017-01-25 | F. Hoffmann-La Roche AG | Aminopyrimidinderivate als lrrk2-modulatoren |
AU2012357038B2 (en) | 2011-12-23 | 2016-05-12 | Cellzome Limited | Pyrimidine-2,4-diamine derivatives as kinase inhibitors |
EP2711365A1 (de) | 2012-09-21 | 2014-03-26 | Chemilia AB | 4-Indazolylamino-2-(2-(indol-3-yl)ethyl)aminopyrimidine verwendbar für die Behandlung von Krebs |
EP2711364A1 (de) | 2012-09-21 | 2014-03-26 | Chemilia AB | 4-(Indolyl oder benzimidazolyl)amino-2-(2-(indol-3-yl)ethyl)aminopyrimidine verwendbar für die Behandlung von Krebs |
US10779980B2 (en) | 2016-04-27 | 2020-09-22 | Synerz Medical, Inc. | Intragastric device for treating obesity |
WO2019117813A1 (en) * | 2017-12-15 | 2019-06-20 | National University Of Singapore | Focal adhesion kinase targeted therapeutics for the treatment of glaucoma and fibrosis |
TW202304434A (zh) * | 2021-04-08 | 2023-02-01 | 大陸商杭州阿諾生物醫藥科技有限公司 | 一種高活性的hpk1激酶抑制劑 |
Family Cites Families (73)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4507146A (en) * | 1982-12-28 | 1985-03-26 | Ciba-Geigy Corporation | 2,4-Diamino-6-halo-5-trifluoromethylpyrimidines having herbicidal activity |
GB8607683D0 (en) | 1986-03-27 | 1986-04-30 | Ici Plc | Anti-tumor agents |
US4983608A (en) * | 1989-09-05 | 1991-01-08 | Hoechst-Roussell Pharmaceuticals, Inc. | N-substituted-4-pyrimidinamines and pyrimidinediamines |
DE4029650A1 (de) | 1990-09-19 | 1992-03-26 | Hoechst Ag | 2-anilino-pyrimidine, verfahren zu ihrer herstellung, sie enthaltene mittel und ihre verwendung als fungizide |
SG64322A1 (en) | 1991-05-10 | 1999-04-27 | Rhone Poulenc Rorer Int | Bis mono and bicyclic aryl and heteroaryl compounds which inhibit egf and/or pdgf receptor tyrosine kinase |
NZ243082A (en) | 1991-06-28 | 1995-02-24 | Ici Plc | 4-anilino-quinazoline derivatives; pharmaceutical compositions, preparatory processes, and use thereof |
DE4131184A1 (de) | 1991-09-19 | 1993-03-25 | Bayer Ag | Wasserbasierte, loesungsmittel- und emulgatorfreie mikrobizide wirkstoffkombination |
DE4137291A1 (de) | 1991-11-13 | 1993-05-19 | Bayer Ag | Verfahren zur kontinuierlichen umsetzung von halogenpyrimidinen mit aminen |
AU2954992A (en) | 1991-11-13 | 1993-06-15 | Mta Kozponti Kemiai Kutato Intezete | Process for preparing n-(arylsulphonyl)-carbamide acid derivates and intermediates useful for carrying out this process |
AU661533B2 (en) | 1992-01-20 | 1995-07-27 | Astrazeneca Ab | Quinazoline derivatives |
FR2686339B1 (fr) | 1992-01-22 | 1994-03-11 | Adir Cie | Nouveaux amides et sulfonamides naphtaleniques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent. |
US5521184A (en) * | 1992-04-03 | 1996-05-28 | Ciba-Geigy Corporation | Pyrimidine derivatives and processes for the preparation thereof |
EP1008589A1 (de) | 1992-05-22 | 2000-06-14 | E.I. Du Pont De Nemours & Company Incorporated | Fungizide Imidazolinone |
US6177401B1 (en) | 1992-11-13 | 2001-01-23 | Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften | Use of organic compounds for the inhibition of Flk-1 mediated vasculogenesis and angiogenesis |
GB9323290D0 (en) | 1992-12-10 | 1994-01-05 | Zeneca Ltd | Quinazoline derivatives |
GB9314893D0 (en) | 1993-07-19 | 1993-09-01 | Zeneca Ltd | Quinazoline derivatives |
GB9314884D0 (en) | 1993-07-19 | 1993-09-01 | Zeneca Ltd | Tricyclic derivatives |
GB9510757D0 (en) | 1994-09-19 | 1995-07-19 | Wellcome Found | Therapeuticaly active compounds |
GB9424233D0 (en) | 1994-11-30 | 1995-01-18 | Zeneca Ltd | Quinazoline derivatives |
ES2180798T3 (es) * | 1995-10-02 | 2003-02-16 | Hoffmann La Roche | Derivados de pirimidina como antagonistas del receptor de 5ht2c. |
GB9523675D0 (en) * | 1995-11-20 | 1996-01-24 | Celltech Therapeutics Ltd | Chemical compounds |
GB9603095D0 (en) | 1996-02-14 | 1996-04-10 | Zeneca Ltd | Quinazoline derivatives |
TW440563B (en) * | 1996-05-23 | 2001-06-16 | Hoffmann La Roche | Aryl pyrimidine derivatives and a pharmaceutical composition thereof |
ES2186908T3 (es) | 1996-07-13 | 2003-05-16 | Glaxo Group Ltd | Compuestos heterociciclos condensados como inhibidores de pproteina-tirosina-quinasas. |
HRP970371A2 (en) | 1996-07-13 | 1998-08-31 | Kathryn Jane Smith | Heterocyclic compounds |
TR199900048T2 (xx) | 1996-07-13 | 1999-04-21 | Glaxo Group Limited | Protein tirozin kinaz inhibit�rleri olarak bisiklik heteroaromatik bile�ikler |
JP3345021B2 (ja) | 1996-08-06 | 2002-11-18 | ファイザー インク. | 置換ピリド―またはピリミド―含有6,6―または6,7―二環式誘導体 |
WO1998009961A1 (en) | 1996-09-04 | 1998-03-12 | Pfizer Inc. | Indazole derivatives and their use as inhibitors of phosphodiesterase (pde) type iv and the production of tumor necrosis factor (tnf) |
ID18494A (id) | 1996-10-02 | 1998-04-16 | Novartis Ag | Turunan pirazola leburan dan proses pembuatannya |
DE19701931C1 (de) | 1997-01-21 | 1998-05-28 | Siemens Ag | Verfahren zur Detektion von Synchronizität zwischen mehreren digitalen Meßreihen mit Hilfe eines Rechners |
DE69836422T2 (de) | 1997-02-19 | 2007-06-14 | Berlex, Inc., Richmond | N-heterocyclische derivate als nos inhibitoren |
TW436485B (en) | 1997-08-01 | 2001-05-28 | American Cyanamid Co | Substituted quinazoline derivatives |
CN1280580A (zh) | 1997-11-11 | 2001-01-17 | 辉瑞产品公司 | 用作抗癌药的噻吩并嘧啶和噻吩并吡啶衍生物 |
CA2321153A1 (en) | 1998-02-17 | 1999-08-19 | Timothy D. Cushing | Anti-viral pyrimidine derivatives |
DE69933680T2 (de) | 1998-08-29 | 2007-08-23 | Astrazeneca Ab | Pyrimidine verbindungen |
CN1144786C (zh) | 1998-09-29 | 2004-04-07 | 美国氰胺公司 | 作为蛋白质酪氨酸激酶抑制剂的取代的3-氰基喹啉 |
US6297258B1 (en) * | 1998-09-29 | 2001-10-02 | American Cyanamid Company | Substituted 3-cyanoquinolines |
GB9828511D0 (en) * | 1998-12-24 | 1999-02-17 | Zeneca Ltd | Chemical compounds |
GB9922171D0 (en) | 1999-09-21 | 1999-11-17 | Zeneca Ltd | Chemical compounds |
GB9924862D0 (en) * | 1999-10-20 | 1999-12-22 | Celltech Therapeutics Ltd | Chemical compounds |
WO2001060816A1 (en) * | 2000-02-17 | 2001-08-23 | Amgen Inc. | Kinase inhibitors |
GB0004887D0 (en) * | 2000-03-01 | 2000-04-19 | Astrazeneca Uk Ltd | Chemical compounds |
GB0004890D0 (en) * | 2000-03-01 | 2000-04-19 | Astrazeneca Uk Ltd | Chemical compounds |
JP2003526686A (ja) | 2000-03-13 | 2003-09-09 | アメリカン・サイアナミド・カンパニー | 結腸ポリープの治療または阻害するためのシアノキノリンの使用 |
US6525051B2 (en) | 2000-03-27 | 2003-02-25 | Schering Aktiengesellschaft | N-heterocyclic derivatives as NOS inhibitors |
JP2004510706A (ja) | 2000-07-07 | 2004-04-08 | キャンサー・リサーチ・テクノロジー・リミテッド | 治療用アクリドン及びアクリジン化合物 |
ES2317923T3 (es) | 2000-08-09 | 2009-05-01 | Astrazeneca Ab | Compuestos de cinolina. |
AU2001277621A1 (en) | 2000-08-09 | 2002-03-04 | Astrazeneca Ab | Antiangiogenic bicyclic derivatives |
CA2416525A1 (en) | 2000-08-09 | 2002-02-14 | Astrazeneca Ab | Indole, azaindole and indazole derivatives having vegf inhibiting activity |
CZ2003486A3 (cs) | 2000-08-21 | 2003-05-14 | Astrazeneca Ab | Chinazolinové deriváty, způsob jejich přípravy a farmaceutický prostředek, který je obsahuje |
JO2654B1 (en) | 2000-09-04 | 2012-06-17 | شركة جانسين فارماسوتيكا ان. في | Multiple aryl caroxa amides are useful as lipid - lowering agents |
ATE430742T1 (de) | 2000-12-21 | 2009-05-15 | Smithkline Beecham Corp | Pyrimidinamine als angiogenesemodulatoren |
RS94703A (en) * | 2001-05-29 | 2007-02-05 | Schering Aktiengesellschaft, | Cdk inhibiting pyrimidines, production thereof and their use as medicaments |
GB0113041D0 (en) | 2001-05-30 | 2001-07-18 | Astrazeneca Ab | Chemical compounds |
JP2005500294A (ja) * | 2001-06-19 | 2005-01-06 | ブリストル−マイヤーズ スクイブ カンパニー | ホスホジエステラーゼ7に対するピリミジン阻害剤 |
US6939874B2 (en) | 2001-08-22 | 2005-09-06 | Amgen Inc. | Substituted pyrimidinyl derivatives and methods of use |
US6927293B2 (en) | 2001-08-30 | 2005-08-09 | Merck & Co., Inc. | Tyrosine kinase inhibitors |
WO2003030909A1 (en) | 2001-09-25 | 2003-04-17 | Bayer Pharmaceuticals Corporation | 2- and 4-aminopyrimidines n-substtituded by a bicyclic ring for use as kinase inhibitors in the treatment of cancer |
EP1453516A2 (de) * | 2001-10-17 | 2004-09-08 | Boehringer Ingelheim Pharma GmbH & Co.KG | 5-substituierte 4-amino-2-phenylamino-pyrimdinderivate und ihre verwendung als beta-amyloid modulatoren |
EP2090571B1 (de) * | 2001-10-17 | 2012-05-16 | Boehringer Ingelheim Pharma GmbH & Co. KG | Pyrimidinderivate, Arzneimittel enthaltend diese Verbindungen, deren Verwendung und Verfahren zu ihrer Herstellung |
TWI329105B (en) | 2002-02-01 | 2010-08-21 | Rigel Pharmaceuticals Inc | 2,4-pyrimidinediamine compounds and their uses |
MXPA04007495A (es) | 2002-02-05 | 2004-11-10 | Wyeth Corp | Proceso para sintesis de acidos n-acil2-amino-4-alcoxi-5-nitrobenzoicos. |
DE10205336A1 (de) | 2002-02-07 | 2003-08-21 | Bdd Group Holding Ag Zug | Deuterierte Biphenylderivate |
GB0206215D0 (en) | 2002-03-15 | 2002-05-01 | Novartis Ag | Organic compounds |
AU2003231231A1 (en) | 2002-05-06 | 2003-11-11 | Bayer Pharmaceuticals Corporation | Pyridinyl amino pyrimidine derivatives useful for treating hyper-proliferative disorders |
UA80767C2 (en) * | 2002-12-20 | 2007-10-25 | Pfizer Prod Inc | Pyrimidine derivatives for the treatment of abnormal cell growth |
DE60322947D1 (de) | 2002-12-20 | 2008-09-25 | Sosei R & D Ltd | Deraufnahme inhibitoren |
WO2004056807A1 (en) * | 2002-12-20 | 2004-07-08 | Pfizer Products Inc. | Pyrimidine derivatives for the treatment of abnormal cell growth |
US7109337B2 (en) * | 2002-12-20 | 2006-09-19 | Pfizer Inc | Pyrimidine derivatives for the treatment of abnormal cell growth |
KR100694732B1 (ko) * | 2003-09-05 | 2007-03-14 | 화이자 프로덕츠 인크. | Cf3-치환 피리미딘의 선택적 합성 |
BRPI0510980A (pt) * | 2004-05-14 | 2007-11-27 | Pfizer Prod Inc | derivados de pirimidina para o tratamento do crescimento anormal de células |
BRPI0511132A (pt) * | 2004-05-14 | 2007-11-27 | Pfizer Prod Inc | derivados de pirimidina e composição farmacêutica compreendendo os mesmos |
WO2005111016A1 (en) * | 2004-05-14 | 2005-11-24 | Pfizer Products Inc. | Pyrimidine derivatives for the treatment of abnormal cell growth |
-
2003
- 2003-12-08 WO PCT/IB2003/005883 patent/WO2004056807A1/en active Application Filing
- 2003-12-08 AP AP2005003438A patent/AP2385A/xx active
- 2003-12-08 MX MXPA06002608A patent/MXPA06002608A/es active IP Right Grant
- 2003-12-08 EP EP03778613A patent/EP1625121B1/de not_active Expired - Lifetime
- 2003-12-08 DE DE60331479T patent/DE60331479D1/de not_active Expired - Lifetime
- 2003-12-08 RS YUP-2006/0097A patent/RS20060097A/sr unknown
- 2003-12-08 AT AT03778613T patent/ATE458731T1/de active
- 2003-12-08 CA CA002529611A patent/CA2529611C/en not_active Expired - Lifetime
- 2003-12-08 GE GEAP20039074A patent/GEP20084357B/en unknown
- 2003-12-08 OA OA1200600067A patent/OA13309A/en unknown
- 2003-12-08 DK DK03778613.4T patent/DK1625121T3/da active
- 2003-12-08 ES ES03778613T patent/ES2338545T3/es not_active Expired - Lifetime
- 2003-12-08 EA EA200600122A patent/EA013248B1/ru not_active IP Right Cessation
- 2003-12-08 SI SI200331771T patent/SI1625121T1/sl unknown
- 2003-12-08 PT PT03778613T patent/PT1625121E/pt unknown
- 2003-12-08 PL PL379330A patent/PL379330A1/pl not_active Application Discontinuation
- 2003-12-08 AU AU2003285614A patent/AU2003285614B2/en not_active Expired
- 2003-12-11 US US10/733,215 patent/US7109335B2/en not_active Expired - Lifetime
- 2003-12-16 TW TW092135619A patent/TWI283673B/zh not_active IP Right Cessation
- 2003-12-17 DO DO2003000793A patent/DOP2003000793A/es unknown
- 2003-12-17 MY MYPI20034835A patent/MY142109A/en unknown
- 2003-12-18 PA PA20038593001A patent/PA8593001A1/es unknown
- 2003-12-18 AR ARP030104715A patent/AR043682A1/es unknown
- 2003-12-18 NL NL1025067A patent/NL1025067C2/nl not_active IP Right Cessation
-
2004
- 2004-01-05 PE PE2004000041A patent/PE20041016A1/es not_active Application Discontinuation
- 2004-12-08 NZ NZ543719A patent/NZ543719A/en not_active IP Right Cessation
-
2005
- 2005-11-20 IL IL172047A patent/IL172047A/en active IP Right Grant
-
2006
- 2006-03-02 CR CR8266A patent/CR8266A/es unknown
- 2006-03-03 TN TNP2006000074A patent/TNSN06074A1/en unknown
- 2006-03-03 EC EC2006006406A patent/ECSP066406A/es unknown
- 2006-08-17 US US11/506,689 patent/US7351712B2/en not_active Expired - Lifetime
-
2008
- 2008-03-31 US US12/059,889 patent/US7674796B2/en not_active Expired - Lifetime
- 2008-07-29 US US12/181,991 patent/US7741336B2/en not_active Expired - Lifetime
-
2009
- 2009-08-14 AU AU2009208172A patent/AU2009208172B2/en not_active Expired
-
2010
- 2010-04-20 CY CY20101100360T patent/CY1110069T1/el unknown
-
2011
- 2011-07-06 CR CR20110380A patent/CR20110380A/es not_active Application Discontinuation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60331479D1 (de) | Pyrimidin-derivate zur behandlung von anormalem zellwachstum | |
DE602006018354D1 (de) | Verfahren zur behandlung von abnormalem zellwachstum | |
EE200200710A (et) | Asendatud bitsüklilised derivaadid ebanormaalse rakukasvu raviks | |
AU2003288603A8 (en) | Pyrimidine derivates for the treatment of abnormal cell growth | |
NO20053483D0 (no) | 4-Anilinokinazolinderivater for behandling av unormal cellevekst | |
DE60325770D1 (de) | Verwendung von rimexolon zur behandlung von augentrockenheit | |
DE60321130D1 (de) | Variation von parametern zur neurostimulation | |
DE602004030907D1 (de) | Zur behandlung von durch crth2 vermittelten krankheiten geeignete pyrimidinderivate | |
DE60011570D1 (de) | Arylpiperazinyl-cyclohexyl indolderivate zur behandlung von depressionen | |
ATE433978T1 (de) | 5,7-diaminopyrazolo 4,3-d pyrimidine zur verwendung in der behandlung von bluthochdruck | |
HUP0501069A2 (en) | Quinazoline derivatives for the treatment of abnormal cell growth | |
AP2241A (en) | Pyrimidine derivatives for the treatment of abnormal cell growth. | |
DE602006003094D1 (de) | 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydrochinolin-derivate zur behandlung von unfruchtbarkeit | |
DE602004022035D1 (de) | Verwendung von pthalide derivativen zur behandlung | |
ATE516040T1 (de) | Zusammensetzung und verwendung zur vorbeugung oder behandlung von stomatitis | |
DE60325496D1 (de) | Verwendung von dihydroimidazolonen zur behandlung von epilepsie bei hunden | |
ATE413867T1 (de) | Methode zur behandlung von bewegungsstörungen mit barbitursäure derivaten. | |
ATE373477T1 (de) | Cci-779 zur behandlung von mantelzelllymphom | |
DE60315376D1 (de) | Vorrichtung zur Behandlung von Erntegut | |
DE59904564D1 (de) | Verwendung von acetylcholinesterase-inhibitoren zur behandlung von delirien | |
DE602004007546D1 (de) | Verwendung von pentadiensäure-derivaten zur behandlung von hyperurikämie | |
ATE345137T1 (de) | Verwendung von 2h-(1,3)-oxazino(3,2-a)indol- derivaten zur behandlung von neuropathischem schmerz | |
DE502004002479D1 (de) | Verwendung von acylcyclohexandion-derivaten zusammen mit ethephon zur behandlung von kernobst | |
DE50301813D1 (de) | Verwendung von wachsartigen verbindungen in fototonern | |
DE502004009105D1 (de) | Verwendung von desoxypeganin zur behandlung schizophrener psychosen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |